MODIFIED SPERM WASHING MEDIUM 9984

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 04,05,06 report with the FDA on 1997-02-10 for MODIFIED SPERM WASHING MEDIUM 9984 manufactured by Irvine Scientific.

Event Text Entries

[44728] 0n friday, 1/10/97, co received notification from a physician at clinic stating a pt that had undergone an intrauterine insemination (iui) procedure on 12/13/96, had experienced a reaction. Co was contacted on friday, 1/10/97, regarding this customer notification. The date of the event was friday, 12/13/96. Co did not receive complete info regarding product lot number of other identification. On 1/15/97 the product lot number was obtained from the customer. On 12/13/96, the pt presented the day after her lh surge for an intrauterine insemination. Standard wash was done twice with a swim up and the supernatant from the swim up had a count of 65 million per mil, 89% motile sperm and was drawn up in a tomcat catheter and intrauterine insemination was done with the swim up sperm. The pellet was placed in the cervix, again with a tomcat catheter. Immediately after the insemination, the speculum was removed and the pt began feeling severe cramping and then became nauseated. Vital signs remain stable, but because of continued cramping and nausea, she was given some smelling salts and 400 milligrams of motrin. Within five minutes after the motrin, the pt developed diffuse hives and swelling. Throughout this entire time, her lung sounds were clear. At this point, she was given sub-cutaneous epinephrine as well as intramuscular benadryl and was then taken by ambulance to hosp, where she was given solu-medrol and observed overnight. She never developed respiratory distress. Of interest is that the pt has a history of asthma, more severe as a child, mild as an adult and a history of multiple allergies to penicillin, sulfa drugs, tetanus, peanuts, pollen and msg, all of which cause full body swelling. It is unclear exactly what she was reacting to. Reports of true allergy to sperm are extremely rare. It may be possible that the pt was allergic to the bovine serum albumin used in the media.
Patient Sequence No: 1, Text Type: D, B5


[7765242] The raw materials used to mfr lot #998460823 were reviewed and found to meet all in-coming raw material specifications. The device history record for the product was reviewed and found to meet all finished product specifications. The lot was mfg according to the mfg protocal and no deviations occurred during the mfg process. No other complaints of this nature have been received on this lot of product. This is the final follow up rpt for this mdr.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2022379-1997-00001
MDR Report Key68757
Report Source04,05,06
Date Received1997-02-10
Date of Report1997-02-10
Date of Event1996-12-13
Date Mfgr Received1997-01-10
Device Manufacturer Date1996-08-01
Date Added to Maude1997-02-19
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameMODIFIED SPERM WASHING MEDIUM
Generic NameSPERM WASHING PROCEDURES
Product CodeHDR
Date Received1997-02-10
Model NumberNA
Catalog Number9984
Lot Number99840823
ID NumberNA
Device Expiration Date1998-08-31
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Age*
Device Eval'ed by MfgrR
Implant FlagN
Date RemovedA
Device Sequence No1
Device Event Key68721
ManufacturerIRVINE SCIENTIFIC
Manufacturer Address2511 DAIMLER ST. SANTA ANA CA 927055588 US
Baseline Brand NameMODIFIED SPERM WASHING MEDIUM
Baseline Model NoNA
Baseline Catalog No9984
Baseline ID*
Baseline Device FamilyCERVICAL CAP
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]24
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK874668
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 1997-02-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.